WASHINGTON — The health and human services deputy secretary said Wednesday that the pharmaceutical industry’s plan to make drug price information more available in television ads might be a “potential salve,” even though the HHS chief, Alex Azar, scoffed at the very same idea in October.

HHS released a proposed policy in October that would mandate drug companies put the list price of their drugs in TV advertisements. The industry trade group PhRMA has said that any such policy would run afoul of the First Amendment, and released its own counter-plan: An ad wouldn’t include the price of a drug, but would instead direct consumers to another place, such as a website, where they could find more information about how much the drug costs.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Your kidding, right ? List price or whats called AWP (average wholesale price)
    is meaningless. This is the point, we have to get away from this number and
    price drugs according to actual cost. Doesn’t anyone see, this is where the PBM’s can take their money and no one will see! It’s all about the spread between AWP and cost that gets lost in the shuffle . Actually it goes in the PBM’s pocket !!!!!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy